We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 81

$520 million settlement expected in AstraZeneca off-label marketing case

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • April 27 2010

The United States Department of Justice is expected to announce shortly a settlement with AstraZeneca plc over allegations that the drug manufacturer improperly promoted off-label uses of its antipsychotic drug, Seroquel

House introduces health insurance bill to repeal antitrust exemption

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • February 24 2010

On Monday, February 22, Representatives Tom Perriello (D-Va.) and Betsy Markey (D-Colo.) introduced H.R. 4626, the Health Insurance Industry Fair Competition Act, to repeal the McCarran-Ferguson Act antitrust exemption for the business of health insurance

Learned intermediary doctrine: Eleventh Circuit upholds summary judgment in favor of manufacturer in lawsuit claiming antidepressant caused suicide

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • May 28 2010

The 11th Circuit Court of Appeals recently relied upon the learned intermediary doctrine in affirming summary judgment in favor of Smithkline Beecham Corp. (“SBC”) in a lawsuit claiming that the antidepressant Paxil caused the decedent to commit suicide

Healthcare news from Capitol Hill and the Department of Health and Human Services September 13, 2010

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • September 13 2010

In early September, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule that seeks to repeal specific elements of Medicaid prescription drug regulations that were published in 2007

Health care legislation imposes tax on annuity income

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • April 26 2010

The Health Care and Reconciliation Act (the "Act"), signed into law on March 30, 2010, imposes a tax on annuity income to help pay for the multi-billion dollar reform package set forth in both the Act and the Patient Protection and Affordable Care Act, signed into law on March 23, 2010

Jury finds in favor of botox manufacturer in off-label use trial

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • May 28 2010

A California jury recently returned a verdict in favor of Allergan, Inc., in a trial involving claims that Allergan’s promotion of an off-label use of its drug Botox caused the death of a pediatric patient suffering from cerebral palsy

Lawmakers agree on year-long "doc fix"

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • December 20 2010

Following the enactment of a one-month fix in order to prevent looming Medicare cuts to physicians for the month of December, Congress moved swiftly to clear a longer-term solution

New government healthcare website unveiled

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • July 2 2010

On July 1, the U.S. Department of Health and Human Services unveiled a new website, HealthCare.gov , to provide consumers with information on their rights and benefits under the Patient Protection and Affordable Care Act

HHS “early innovator” grants announced

  • Edwards Wildman Palmer LLP
  • -
  • USA
  • -
  • November 8 2010

In late-October, the Department of Health and Human Services (HHS) announced state grants to design and implement information technology in order to operate health insurance exchanges

Northern Ireland to bring back compensation for pleural plaques

  • Edwards Wildman Palmer LLP
  • -
  • United Kingdom
  • -
  • June 2 2010

The Northern Ireland Executive has published its analysis of the responses to its consultation paper on pleural plaques